Marshall Wace, LLP Roivant Sciences Ltd. Transaction History

Marshall Wace, LLP

  • $74.4 Billion
  • Q1 2025

A detailed history of Marshall Wace, LLP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Marshall Wace, LLP holds 271,823 shares of ROIV stock, worth $3.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
271,823
Previous 2,946,954 90.78%
Holding current value
$3.05 Million
Previous $34.9 Million 92.13%
% of portfolio
0.0%
Previous 0.04%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$10.09 - $12.08 $27 Million - $32.3 Million
-2,675,131 Reduced 90.78%
271,823 $2.74 Million
Q4 2024

Feb 13, 2025
BUY
$11.16 - $12.71 $16.8 Million - $19.1 Million
1,505,062 Added 104.38%
2,946,954 $34.9 Million
Q3 2024

Nov 14, 2024
BUY
$10.17 - $12.5 $7.39 Million - $9.09 Million
727,132 Added 101.73%
1,441,892 $16.6 Million
Q2 2024

Aug 14, 2024
BUY
$10.36 - $11.74 $6.84 Million - $7.76 Million
660,660 Added 1221.18%
714,760 $7.56 Million
Q1 2024

May 15, 2024
SELL
$9.87 - $11.8 $1.8 Million - $2.16 Million
-182,743 Reduced 77.16%
54,100 $570,000
Q4 2023

Feb 14, 2024
BUY
$8.38 - $11.58 $1.98 Million - $2.74 Million
236,843 New
236,843 $2.66 Million
Q2 2023

Aug 14, 2023
BUY
$7.09 - $10.08 $7.75 Million - $11 Million
1,093,255 Added 364.84%
1,392,906 $14 Million
Q1 2023

May 15, 2023
BUY
$6.92 - $9.98 $1.73 Million - $2.5 Million
250,670 Added 511.77%
299,651 $2.21 Million
Q4 2022

Feb 14, 2023
SELL
$3.36 - $7.99 $317,291 - $754,511
-94,432 Reduced 65.85%
48,981 $391,000
Q3 2022

Nov 14, 2022
BUY
$0.51 - $4.84 $73,140 - $694,118
143,413 New
143,413 $461,000

Others Institutions Holding ROIV

# of Institutions
334
Shares Held
496M
Call Options Held
3.67M
Put Options Held
754K
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $7.9B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email